Searches for eClinicalOS lead to a platform launched by Merge Healthcare in 2012 that later appears under IBM. Its current status is unclear in public sources, so this page helps you confirm what you actually use, then plan an orderly replacement or a side-by-side test.
Free sandbox · No credit card · 21 CFR Part 11 aligned
Items ready
3 of 7
Blocking
2
What to know first
The vendor
A 2012 launch announcement described eClinical OS as a single web system supporting trials in any phase, with one interface and one contract for end-to-end study support. Follow-up coverage mentioned a marketplace of services requested within a study workflow and mobile alerts and metrics. Later, a company profile on a trade site lists Merge's eClinical division as part of IBM with eClinical OS as its flagship product alongside a CTMS for investigators.
That is where the trail goes quiet in the sources we could check. It may mean the product has been renamed, absorbed into another offering, sold to a new owner or simply left out of public coverage. Rather than guess, treat the first task as a fact-finding one: ask your account contact, in writing, who owns the product, what support and maintenance commitments run through your contract term, and what the roadmap is. If the answers are vague, treat that as information. The checks in the EDC vendor audit checklist are a good template for those questions.
Some pages that appear for this search term may concern a different, similarly named product. If you reached this page looking for something else, the EDC vendor comparison guide gives a neutral way to assess any vendor.
Vendor continuity
These are neutral questions. Answers should be in writing and filed with your vendor qualification records.
| Question | What a good answer looks like | Why it matters |
|---|---|---|
| Who owns the product today? | A named company and a current contract party. | A change of owner can change support, pricing and priorities. |
| Is the software under active development? | A release history and a stated roadmap. | Security fixes and browser compatibility need ongoing work. |
| What is the end-of-support position? | A written commitment through the length of your studies. | A long study can outlive a product. |
| Can we export everything? | Data, audit trail, queries, signatures and the dictionary, in documented formats. | The export defines how painful leaving will be. |
| What does validation look like after updates? | Release notes and a regression summary. | You carry the responsibility for your own validated use. |
| What does a change cost? | A rate card. | Change cost grows as the vendor shrinks service teams. |
Build one live-study excerpt in the free sandbox and see how forms, checks and exports compare with your current system. Every feature, no credit card.
Replacement plan
Product, version, owner, contract term, support terms and notice period. Put them on one page.
For each study record phase, status, lock date and whether it will still be open next year. Only studies that will not finish within the contract need a plan.
Pull a full export of one closed study including the audit trail and dictionary. Do this before you need it.
Closed studies are usually archived, not migrated. Live studies can run to lock where they are. New studies start on the replacement. Read how to switch EDC vendors mid-study if you must move a live one.
Run the same excerpt through two or three candidates, including the Viedoc and Castor comparisons if you want established alternatives.
Use a common request block, the EDC quote request template.
File the evaluation, the vendor statements and the sign-offs with your vendor qualification records.
Where Capture fits
Capture is built for teams that want to own the build. The AI study builder drafts visits and forms from an uploaded protocol, a team edits and approves them, and everything runs under one audit trail. Pricing is public: Core is $1,000 per month including one live study plus $50 per participant per month.
| Assessment | Screen | Baseline | Wk 4 | Wk 12 | EOS |
|---|---|---|---|---|---|
| Demographics | |||||
| Vital signs | |||||
| Laboratory | |||||
| Adverse events | |||||
| Symptom diary | D | D | D |
x = eCRF at visit · D = participant diary
Fair view
If your studies are running, locked on schedule and supported, a replacement can wait. A migration costs time and carries risk, and the safest moment to change is between studies. Keep the system running to lock, archive it with its audit trail, and start the next study elsewhere. The hidden EDC fees page is a useful read before any new contract, and the cost worksheet for 500 participants shows Capture's list-rate arithmetic for planning.
Public sources describe eClinical OS as a web-based clinical trial platform launched by Merge Healthcare in 2012 and later associated with IBM. We could not confirm its current status, so check with your vendor.
We do not know and make no claim. Ask the vendor for its support commitment and roadmap in writing.
Established cloud EDC options include Viedoc, Castor and TrialMaster, and self-serve options such as Capture. Test each on the same protocol excerpt.
It is a project, not a toggle. Most teams let live studies run to lock and start new ones on the new system. See the guide on switching EDC vendors mid-study.
Test it now. A full export including the audit trail and data dictionary is the first thing to verify before any move.
Yes. The free sandbox has every feature with no credit card and no time limit.
Yes. Capture is suitable for Phase 1 to 3.
Keep exploring
How to switch EDC vendors mid-study
If you must move a live study.
EDC vendor audit checklist
Qualification questions for any vendor.
TrialMaster alternatives
An established EDC compared.
Castor EDC alternatives
A cloud EDC compared.
How to choose an EDC system
A vendor-neutral buyer's guide.
Pricing
Core, Full Platform and Enterprise.
Free sandbox with every feature. No credit card, no sales call, and you pay only once you go live.